Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patients

BACKGROUND: To evaluate therapeutic outcomes of interferon alpha-2a (IFNα2a) treatment in patients with Behcet’s disease who were refractory to immunosuppressive agents. METHODS: This retrospective case series reviewed the medical records of 5 patients with refractory Behcet uveitis from January 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji Hwan, Lee, Christopher Seungkyu, Lee, Sung Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819294/
https://www.ncbi.nlm.nih.gov/pubmed/29463220
http://dx.doi.org/10.1186/s12886-018-0719-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819294/
https://www.ncbi.nlm.nih.gov/pubmed/29463220
http://dx.doi.org/10.1186/s12886-018-0719-0

Ejemplares similares